These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27820956)

  • 1. The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients.
    Huang Y; Zhang H; Zhang M; Li W; Wang J; Hu J
    J Neurogastroenterol Motil; 2017 Apr; 23(2):254-261. PubMed ID: 27820956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroparesis-Related Symptoms in Patients With Type 2 Diabetes Mellitus: Early Detection, Risk Factors, and Prevalence.
    Asghar S; Asghar S; Shahid S; Sajjad H; Abdul Nasir J; Usman M
    Cureus; 2023 Mar; 15(3):e35787. PubMed ID: 37025723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms Suggestive of Gastroparesis in a Community-Based Cohort of European Americans and African Americans with Type 2 Diabetes Mellitus.
    Brown LK; Xu J; Freedman BI; Hsu FC; Bowden DW; Koch KL
    Dig Dis Sci; 2020 Aug; 65(8):2321-2330. PubMed ID: 31820181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life.
    Parkman HP; Wilson LA; Hasler WL; McCallum RW; Sarosiek I; Koch KL; Abell TL; Schey R; Kuo B; Snape WJ; Nguyen L; Farrugia G; Grover M; Clarke J; Miriel L; Tonascia J; Hamilton F; Pasricha PJ
    Dig Dis Sci; 2019 Aug; 64(8):2242-2255. PubMed ID: 30852767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with Type 1 diabetes.
    Kofod-Andersen K; Tarnow L
    J Diabetes Complications; 2012; 26(2):89-93. PubMed ID: 22459243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study on patients with diabetes and symptoms of gastroparesis - associations with impaired quality of life and increased depressive and anxiety symptoms.
    Teigland T; Iversen MM; Sangnes DA; Dimcevski G; Søfteland E
    J Diabetes Complications; 2018 Jan; 32(1):89-94. PubMed ID: 29153755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis.
    Hasler WL; Parkman HP; Wilson LA; Pasricha PJ; Koch KL; Abell TL; Snape WJ; Farrugia G; Lee L; Tonascia J; Unalp-Arida A; Hamilton F;
    Am J Gastroenterol; 2010 Nov; 105(11):2357-67. PubMed ID: 20588262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
    Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.
    Lacy BE; Everhart K; Crowell MD
    Dig Dis Sci; 2019 May; 64(5):1281-1287. PubMed ID: 30382539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and content validity of a gastroparesis cardinal symptom index daily diary.
    Revicki DA; Camilleri M; Kuo B; Norton NJ; Murray L; Palsgrove A; Parkman HP
    Aliment Pharmacol Ther; 2009 Sep; 30(6):670-80. PubMed ID: 19558608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
    Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
    Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
    Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
    Aliment Pharmacol Ther; 2003 Jul; 18(1):141-50. PubMed ID: 12848636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.
    Pasricha PJ; Yates KP; Nguyen L; Clarke J; Abell TL; Farrugia G; Hasler WL; Koch KL; Snape WJ; McCallum RW; Sarosiek I; Tonascia J; Miriel LA; Lee L; Hamilton F; Parkman HP
    Gastroenterology; 2015 Dec; 149(7):1762-1774.e4. PubMed ID: 26299414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes.
    Almogbel RA; Alhussan FA; Alnasser SA; Algeffari MA
    Int J Health Sci (Qassim); 2016 Jul; 10(3):397-404. PubMed ID: 27610063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis.
    Revicki DA; Speck RM; Lavoie S; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
    Neurogastroenterol Motil; 2019 Apr; 31(4):e13553. PubMed ID: 30734412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and symptoms suggestive of gastroparesis in patients with type 2 diabetes and neuropathy.
    Boaz M; Kislov J; Dickman R; Wainstein J
    J Diabetes Complications; 2011; 25(5):325-8. PubMed ID: 21813291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
    Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
    Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of
    Mahjoub F; Salari R; Yousefi M; Mohebbi M; Saki A; Rezayat KA
    Electron Physician; 2018 Jul; 10(7):6997-7007. PubMed ID: 30128090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
    Heckert J; Parkman HP
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience.
    Barbash B; Mehta D; Siddiqui MT; Chawla L; Dworkin B
    Cureus; 2019 Dec; 11(12):e6430. PubMed ID: 31993268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.